{"id":"Diagnostic_criteria_for_preeclampsia.v1","gdl_version":"2.0","concept":"gt0001","language":{"original_language":"ISO_639-1::en"},"description":{"original_author":{"name":"Pau Garcia, Kevin Arjona, Katja Wilde","email":"garcia.i.morales.pau@stud.ki.se","organisation":"Karolinska Institutet","date":"2024-05-21"},"lifecycle_state":"Not set","details":{"en":{"id":"en","keywords":["Obstetrics","Preeclamsia","Criteria","Hypertension","Pregnancy"],"purpose":"Diagnostic criteria for the diagnosis of preeclampsia without severe features.\n\nTo diagnose preeclampsia without severe features.","use":"Diagnostic criteria for the diagnosis of preeclampsia without severe features in pregnant women with new onset of hypertension (Systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg) and proteinuria or the new onset of hypertension plus significant end-organ dysfunction with or without proteinuria in a previously normotensive patient, after 20 weeks of gestation.\n\nUse to  diagnose preeclampsia without severe features:. The tool assesses parameters related to the diagonsis of preeclampsia without severe features: quantitative urinary protein, urine creatinine, systolic and diastolic blood pressure, pulmonary edema, liver transaminases, proteinuria, platelet count, serum creatinine, hemolysis, and signs/symptoms of preeclampsia and preeclampsia with severe features.\n\nHow does it work?? \n","misuse":" Do not use in pregnant women with  preeclampsia who have severe hypertension (systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥110 mmHg) and/or specific signs or symptoms of significant end-organ dysfunction that signify the severe end of the preeclampsia spectrum."},"de":{"id":"de","purpose":"Zur Diagnose der Präeklampsie ohne schwere Merkmale."}},"other_details":{"references":"American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia. Obstet Gynecol 2020; 135:e237.\n\nMagee LA, Brown MA, Hall DR, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 2022; 27:148."},"other_contributors":[]},"definition":{"data_bindings":{"gt0002":{"id":"gt0002","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.lab_test_urine_protein.v0","template_id":"openEHR-EHR-OBSERVATION.lab_test_urine_protein.v0","elements":{"gt0003":{"id":"gt0003","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0078.2]"}}},"gt0004":{"id":"gt0004","type":"OUTPUT","model_id":"openEHR-EHR-EVALUATION.problem_diagnosis.v1","template_id":"openEHR-EHR-EVALUATION.problem_diagnosis.v1","elements":{"gt0005":{"id":"gt0005","path":"/data[at0001]/items[at0002]"}}},"gt0006":{"id":"gt0006","type":"OUTPUT","model_id":"openEHR-EHR-EVALUATION.problem_diagnosis.v1","template_id":"openEHR-EHR-EVALUATION.problem_diagnosis.v1","elements":{"gt0007":{"id":"gt0007","path":"/data[at0001]/items[at0002]"}}},"gt0008":{"id":"gt0008","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.lab_test_creatinine.v1","template_id":"openEHR-EHR-OBSERVATION.lab_test_creatinine.v1","elements":{"gt0009":{"id":"gt0009","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0005]"}}},"gt0016":{"id":"gt0016","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.blood_pressure.v2","template_id":"openEHR-EHR-OBSERVATION.blood_pressure.v2","elements":{"gt0017":{"id":"gt0017","path":"/data[at0001]/events[at0006]/data[at0003]/items[at0004]"},"gt0018":{"id":"gt0018","path":"/data[at0001]/events[at0006]/data[at0003]/items[at0005]"}}},"gt0026":{"id":"gt0026","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.brugada_criteria_for_ventricular_tachycardia.v0","template_id":"openEHR-EHR-OBSERVATION.brugada_criteria_for_ventricular_tachycardia.v0","elements":{"gt0027":{"id":"gt0027","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0004]"}}},"gt0028":{"id":"gt0028","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.glasgow_imrie_criteria_for_severity_of_acute_pancreatitis.v1","template_id":"openEHR-EHR-OBSERVATION.glasgow_imrie_criteria_for_severity_of_acute_pancreatitis.v1","elements":{"gt0029":{"id":"gt0029","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0010]"},"gt0033":{"id":"gt0033","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0008]"},"gt0034":{"id":"gt0034","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0009]"},"gt0035":{"id":"gt0035","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0011]"},"gt0036":{"id":"gt0036","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0007]"},"gt0037":{"id":"gt0037","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0006]"}}},"gt0030":{"id":"gt0030","type":"INPUT","model_id":"openEHR-EHR-OBSERVATION.migraine.v0","template_id":"openEHR-EHR-OBSERVATION.migraine.v0","elements":{"gt0031":{"id":"gt0031","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0004]"},"gt0032":{"id":"gt0032","path":"/data[at0001]/events[at0002]/data[at0003]/items[at0031]"}}}},"rules":{"gt0019":{"id":"gt0019","priority":1,"then":["$gt0005|Preeclampsia| = 'Preeclamsia'"],"when":["$gt0033|Proteinuria ≥0.3 g in a 24-hour urine| == 1|local::at0021|Yes|","$gt0003|Quantitative urinary protein| / $gt0009|Urine Creatinine| >= 0.3","$gt0034|Dipstick ≥2+| == 1|local::at0019|Yes|"]},"gt0020":{"id":"gt0020","priority":2,"then":["$gt0005|Preeclampsia| = 'Preeclamsia'"],"when":["$gt0035|Platelet count <100,000/microL| == 1|local::at0015|Yes|"]},"gt0021":{"id":"gt0021","priority":3,"then":["$gt0005|Preeclampsia| = 'Preeclamsia'"],"when":["$gt0036|Serum creatinine >1.1 mg/dL (97.2 micromol/L)| == 1|local::at0023|Yes|","$gt0037|Doubling of the creatinine concentration (no kidney disease)| == 1|local::at0025|Yes|"]},"gt0022":{"id":"gt0022","priority":4,"then":["$gt0005|Preeclampsia| = 'Preeclamsia'"],"when":["$gt0029|Liver transaminases at least twice the upper limit| == 1|local::at0017|Yes|"]},"gt0023":{"id":"gt0023","priority":5,"then":["$gt0005|Preeclampsia| = 'Preeclamsia'"],"when":["$gt0027|Pulmonary edema| == local::at0025|Yes|"]},"gt0024":{"id":"gt0024","priority":6,"then":["$gt0005|Preeclampsia| = 'Preeclamsia'"],"when":["$gt0031|Headache| == 1|local::at0006|Yes|"]},"gt0025":{"id":"gt0025","priority":7,"then":["$gt0005|Preeclampsia| = 'Preeclamsia'"],"when":["$gt0032|Visual symptoms (eg, blurred vision, flashing lights or sparks, scotomata)| == 1|local::at0033|Yes|"]},"gt0038":{"id":"gt0038","priority":8,"then":["$gt0005|Preeclampsia| = 'Preeclampsia with severe features'"],"when":["$gt0017|Systolic| >= 160,mm[Hg]","$gt0018|Diastolic| >= 110,mm[Hg]"]}},"pre_conditions":["$gt0017|Systolic| >= 140,mm[Hg]","$gt0018|Diastolic| >= 90,mm[Hg]"]},"ontology":{"term_definitions":{"en":{"id":"en","terms":{"gt0001":{"id":"gt0001","text":"Diagnostic criteria for preeclampsia","description":"Preeclampsia is considered superimposed when it occurs in a patient with chronic hypertension. Superimposed preeclampsia is characterized by worsening or resistant hypertension (especially acutely), the new onset of proteinuria or a sudden increase in proteinuria, and/or significant new end-organ dysfunction in a patient with chronic hypertension. It typically occurs after 20 weeks of gestation or postpartum.\n\nDefinitions/diagnostic criteria for preeclampsia are generally similar worldwide except the International Society for the Study of Hypertension in Pregnancy definition also includes signs of uteroplacental dysfunction (eg, fetal growth restriction, abnormal angiogenic markers, abnormal umbilical artery Doppler, abruption, fetal demise).\n\nA tool for detecting superimposed preeclampsia in patients. Superimposed preeclampsia is characterized by worsening or resistant hypertension (especially acutely), the new onset of proteinuria or a sudden increase in proteinuria, and/or significant new end-organ dysfunction in a patient with chronic hypertension. It typically occurs after 20 weeks of gestation or postpartum.\n\nDefinitions/diagnostic criteria for preeclampsia are generally similar worldwide, with the exception that the International Society for the Study of Hypertension in Pregnancy definition includes signs of uteroplacental dysfunction (e.g., fetal growth restriction, abnormal angiogenic markers, abnormal umbilical artery Doppler, abruption, fetal demise).\n"},"gt0003":{"id":"gt0003","text":"Quantitative urinary protein"},"gt0005":{"id":"gt0005","text":"Preeclampsia"},"gt0007":{"id":"gt0007","text":"Observations"},"gt0009":{"id":"gt0009","text":"Urine Creatinine"},"gt0017":{"id":"gt0017","text":"Systolic"},"gt0018":{"id":"gt0018","text":"Diastolic"},"gt0019":{"id":"gt0019","text":"1 Proteinuria ","description":"Proteinuria ≥0.3 g in a 24-hour urine specimen or protein/creatinine ratio ≥0.3 (30 mg/mmol) in a random urine specimen or dipstick ≥2+ if a quantitative measurement is unavailable"},"gt0020":{"id":"gt0020","text":"2 Platelet","description":"Platelet count <100,000/microL"},"gt0021":{"id":"gt0021","text":"3 creatinine","description":"Serum creatinine >1.1 mg/dL (97.2 micromol/L) or doubling of the creatinine concentration in the absence of other kidney disease"},"gt0022":{"id":"gt0022","text":"4 transaminases","description":"Liver transaminases at least twice the upper limit of the normal concentrations for the local laboratory"},"gt0023":{"id":"gt0023","text":"5 Pulmonary edema","description":"Pulmonary edema present"},"gt0024":{"id":"gt0024","text":"6 headache","description":"New-onset and persistent headache not accounted for by alternative diagnoses and not responding to usual doses of analgesics (Response to analgesia does not exclude the possibility of preeclampsia)."},"gt0025":{"id":"gt0025","text":"7 Visual symptoms","description":"Visual symptoms (eg, blurred vision, flashing lights or sparks, scotomata)"},"gt0027":{"id":"gt0027","text":"Pulmonary edema"},"gt0029":{"id":"gt0029","text":"Liver transaminases at least twice the upper limit"},"gt0031":{"id":"gt0031","text":"Headache"},"gt0032":{"id":"gt0032","text":"Visual symptoms (eg, blurred vision, flashing lights or sparks, scotomata)"},"gt0033":{"id":"gt0033","text":"Proteinuria ≥0.3 g in a 24-hour urine"},"gt0034":{"id":"gt0034","text":"Dipstick ≥2+"},"gt0035":{"id":"gt0035","text":"Platelet count <100,000/microL"},"gt0036":{"id":"gt0036","text":"Serum creatinine >1.1 mg/dL (97.2 micromol/L)"},"gt0037":{"id":"gt0037","text":"Doubling of the creatinine concentration (no kidney disease)"},"gt0038":{"id":"gt0038","text":"8 blood pressure","description":"If systolic blood pressure is ≥160 mmHg and/or diastolic blood pressure is ≥110 mmHg, confirmation within minutes is sufficient."}}},"es":{"id":"es","terms":{"gt0001":{"text":"Criterios diagnosticos de preeclampsia","description":"*(en) Preeclampsia is considered superimposed when it occurs in a patient with chronic hypertension. Superimposed preeclampsia is characterized by worsening or resistant hypertension (especially acutely), the new onset of proteinuria or a sudden increase in proteinuria, and/or significant new end-organ dysfunction in a patient with chronic hypertension. It typically occurs after 20 weeks of gestation or postpartum.\n\nDefinitions/diagnostic criteria for preeclampsia are generally similar worldwide except the International Society for the Study of Hypertension in Pregnancy definition also includes signs of uteroplacental dysfunction (eg, fetal growth restriction, abnormal angiogenic markers, abnormal umbilical artery Doppler, abruption, fetal demise).","id":"gt0001"},"gt0003":{"text":"Proteínas en la urina (Proteinuria) - Quantitativo","id":"gt0003"},"gt0005":{"text":"Preeclampsia","id":"gt0005"},"gt0007":{"text":"Preeclampsia severa","id":"gt0007"},"gt0009":{"text":"Creatinina en urina","id":"gt0009"},"gt0017":{"text":"Sistólica","id":"gt0017"},"gt0018":{"text":"Diastólica","id":"gt0018"},"gt0019":{"text":"1 Proteinuria","description":"Proteinuria ≥0,3 g en una muestra de orina de 24 horas o relación proteína/creatinina ≥0,3 (30 mg/mmol) en una muestra de orina aleatoria o tira reactiva ≥2+ si no se dispone de una medición cuantitativa.","id":"gt0019"},"gt0020":{"text":"2 Recuento plaquetario","description":"Recuento plaquetario <100,000/microL","id":"gt0020"},"gt0021":{"text":"3 Creatinina","description":"Creatinina en sangre >1,1 mg/dL (97,2 micromol/L) o duplicación de la concentración de creatinina en ausencia de otra enfermedad renal.","id":"gt0021"},"gt0022":{"text":"4 Transaminasas","description":"Transaminasas hepáticas al menos dos veces el límite superior de las concentraciones normales para el laboratorio local.","id":"gt0022"},"gt0023":{"text":"5 Edema pulmonar","description":"Edema pulmonar presente","id":"gt0023"},"gt0024":{"text":"Dolor de cabeza","description":"Dolor de cabeza persistente y de nueva aparición que no se explica por diagnósticos alternativos y que no responde a las dosis habituales de analgésicos (la respuesta a la analgesia no excluye la posibilidad de preeclampsia).","id":"gt0024"},"gt0025":{"text":"7 Problemas de visión","description":"Cambios en la visión (per ejemplo, pérdida temporal de esta, visión borrosa o sensibilidad a la luz).","id":"gt0025"},"gt0027":{"id":"gt0027","text":"*(en) Pulmonary edema"},"gt0029":{"id":"gt0029","text":"*(en) Albumin <3.2 g/dL (32 g/L)"},"gt0031":{"id":"gt0031","text":"*(en) Headache"},"gt0032":{"id":"gt0032","text":"*(en) Visual symptoms (eg, blurred vision, flashing lights or sparks, scotomata)"},"gt0033":{"id":"gt0033","text":"*(en) Urea >44.8 mg/dL (16 mmol/L)"},"gt0034":{"id":"gt0034","text":"*(en) LDH >600 IU/L"},"gt0035":{"id":"gt0035","text":"*(en) Platelet count <100,000/microL"},"gt0036":{"id":"gt0036","text":"*(en) Serum creatinine >1.1 mg/dL (97.2 micromol/L)"},"gt0037":{"id":"gt0037","text":"*(en) Doubling of the creatinine concentration (no kidney disease)"},"gt0038":{"id":"gt0038","text":"*(en) 8","description":"*(en) If systolic blood pressure is ≥160 mmHg and/or diastolic blood pressure is ≥110 mmHg, confirmation within minutes is sufficient."}}},"ca":{"id":"ca","terms":{"gt0001":{"id":"gt0001","text":"*(en) Diagnostic criteria for preeclampsia","description":"*(en) Preeclampsia is considered superimposed when it occurs in a patient with chronic hypertension. Superimposed preeclampsia is characterized by worsening or resistant hypertension (especially acutely), the new onset of proteinuria or a sudden increase in proteinuria, and/or significant new end-organ dysfunction in a patient with chronic hypertension. It typically occurs after 20 weeks of gestation or postpartum.\n\nDefinitions/diagnostic criteria for preeclampsia are generally similar worldwide except the International Society for the Study of Hypertension in Pregnancy definition also includes signs of uteroplacental dysfunction (eg, fetal growth restriction, abnormal angiogenic markers, abnormal umbilical artery Doppler, abruption, fetal demise)."},"gt0003":{"id":"gt0003","text":"*(en) Quantitative urinary protein"},"gt0005":{"id":"gt0005","text":"*(en) Preeclampsia"},"gt0007":{"id":"gt0007","text":"*(en) Preeclampsia with severe features"},"gt0009":{"text":"Creatinina en orina","id":"gt0009"},"gt0017":{"text":"Sistòlica","id":"gt0017"},"gt0018":{"text":"Diastòlica","id":"gt0018"},"gt0019":{"text":"1 Proteïnúria","description":"Proteïnúria ≥0,3 g en una mostra d'orina de 24 hores o proporció proteïna/creatinina ≥0,3 (30 mg/mmol) en una mostra d'orina aleatòria o tira reactiva ≥2+ si no hi ha una mesura quantitativa disponible","id":"gt0019"},"gt0020":{"text":"2 Recompte plaquetari","description":"Recompte plaquetari <100,000/microL","id":"gt0020"},"gt0021":{"text":"3 Creatinina ","description":"Creatinina en sang > 1,1 mg/dL (97,2 micromol/L) o duplicació de la concentració de creatinina en absència d'una altra malaltia renal.","id":"gt0021"},"gt0022":{"text":"4 Transaminases","description":"Les transaminases hepàtiques com a mínim el doble del límit superior de les concentracions normals per al laboratori local.","id":"gt0022"},"gt0023":{"text":"5 Edema pulmonar","description":"Presència d'edema pulmonar","id":"gt0023"},"gt0024":{"text":"6 Cefalea","description":"Cefalea de nova aparició i persistent no explicada per diagnòstics alternatius i que no respon a les dosis habituals d'analgèsics (la resposta a l'analgèsia no exclou la possibilitat de preeclampsia).","id":"gt0024"},"gt0025":{"text":"7 Cambis en la visió","description":"Cambis visuals (per exemple, visió borrosa, llums intermitents o espurnes, escotomes).","id":"gt0025"},"gt0027":{"id":"gt0027","text":"*(en) Pulmonary edema"},"gt0029":{"id":"gt0029","text":"*(en) Albumin <3.2 g/dL (32 g/L)"},"gt0031":{"id":"gt0031","text":"*(en) Headache"},"gt0032":{"id":"gt0032","text":"*(en) Visual symptoms (eg, blurred vision, flashing lights or sparks, scotomata)"},"gt0033":{"id":"gt0033","text":"*(en) Urea >44.8 mg/dL (16 mmol/L)"},"gt0034":{"id":"gt0034","text":"*(en) LDH >600 IU/L"},"gt0035":{"id":"gt0035","text":"*(en) Platelet count <100,000/microL"},"gt0036":{"id":"gt0036","text":"*(en) Serum creatinine >1.1 mg/dL (97.2 micromol/L)"},"gt0037":{"id":"gt0037","text":"*(en) Doubling of the creatinine concentration (no kidney disease)"},"gt0038":{"id":"gt0038","text":"*(en) 8","description":"*(en) If systolic blood pressure is ≥160 mmHg and/or diastolic blood pressure is ≥110 mmHg, confirmation within minutes is sufficient."}}},"fr":{"id":"fr","terms":{"gt0001":{"id":"gt0001","text":"*(en) Diagnostic criteria for preeclampsia","description":"*(en) Preeclampsia is considered superimposed when it occurs in a patient with chronic hypertension. Superimposed preeclampsia is characterized by worsening or resistant hypertension (especially acutely), the new onset of proteinuria or a sudden increase in proteinuria, and/or significant new end-organ dysfunction in a patient with chronic hypertension. It typically occurs after 20 weeks of gestation or postpartum.\n\nDefinitions/diagnostic criteria for preeclampsia are generally similar worldwide except the International Society for the Study of Hypertension in Pregnancy definition also includes signs of uteroplacental dysfunction (eg, fetal growth restriction, abnormal angiogenic markers, abnormal umbilical artery Doppler, abruption, fetal demise)."},"gt0003":{"id":"gt0003","text":"*(en) Quantitative urinary protein"},"gt0005":{"id":"gt0005","text":"*(en) Preeclampsia"},"gt0007":{"id":"gt0007","text":"*(en) Preeclampsia with severe features"},"gt0009":{"text":"Créatinine urinaire","id":"gt0009"},"gt0017":{"text":"Systolique","id":"gt0017"},"gt0018":{"text":"Diastolique","id":"gt0018"},"gt0019":{"text":"1 Protéinurie","description":"Protéinurie ≥0,3 g dans un échantillon d'urine de 24 heures ou rapport protéine/créatinine ≥0,3 (30 mg/mmol) dans un échantillon d'urine aléatoire ou une bandelette réactive ≥2+ si une mesure quantitative n'est pas disponible","id":"gt0019"},"gt0020":{"text":"2 Numération plaquettaire","description":"La numération plaquettaire est <100,000/microL","id":"gt0020"},"gt0021":{"text":"3 Créatinine sérique","description":"Créatinine sérique > 1,1 mg/dL (97,2 micromol/L) ou doublement de la concentration de créatinine en l'absence d'autre maladie rénale.","id":"gt0021"},"gt0022":{"text":"4 Transaminases","description":"Transaminases hépatiques au moins deux fois supérieures à la limite supérieure des concentrations normales pour le laboratoire local.","id":"gt0022"},"gt0023":{"text":"5 Œdème pulmonaire","description":"Œdème pulmonaire present","id":"gt0023"},"gt0024":{"text":"6 Migraine","description":"Céphalées d'apparition récente et persistantes non expliquées par d'autres diagnostics et ne répondant pas aux doses habituelles d'analgésiques (la réponse à l'analgésie n'exclut pas la possibilité de prééclampsie).","id":"gt0024"},"gt0025":{"text":"7 Symptômes visuels","description":"Symptômes visuels (par exemple, vision floue, lumières clignotantes ou étincelles, scotomes)","id":"gt0025"},"gt0027":{"id":"gt0027","text":"*(en) Pulmonary edema"},"gt0029":{"id":"gt0029","text":"*(en) Albumin <3.2 g/dL (32 g/L)"},"gt0031":{"id":"gt0031","text":"*(en) Headache"},"gt0032":{"id":"gt0032","text":"*(en) Visual symptoms (eg, blurred vision, flashing lights or sparks, scotomata)"},"gt0033":{"id":"gt0033","text":"*(en) Urea >44.8 mg/dL (16 mmol/L)"},"gt0034":{"id":"gt0034","text":"*(en) LDH >600 IU/L"},"gt0035":{"id":"gt0035","text":"*(en) Platelet count <100,000/microL"},"gt0036":{"id":"gt0036","text":"*(en) Serum creatinine >1.1 mg/dL (97.2 micromol/L)"},"gt0037":{"id":"gt0037","text":"*(en) Doubling of the creatinine concentration (no kidney disease)"},"gt0038":{"id":"gt0038","text":"*(en) 8","description":"*(en) If systolic blood pressure is ≥160 mmHg and/or diastolic blood pressure is ≥110 mmHg, confirmation within minutes is sufficient."}}},"de":{"id":"de","terms":{"gt0001":{"id":"gt0001","text":"*(en) Diagnostic criteria for preeclampsia","description":"*(en) Preeclampsia is considered superimposed when it occurs in a patient with chronic hypertension. Superimposed preeclampsia is characterized by worsening or resistant hypertension (especially acutely), the new onset of proteinuria or a sudden increase in proteinuria, and/or significant new end-organ dysfunction in a patient with chronic hypertension. It typically occurs after 20 weeks of gestation or postpartum.\n\nDefinitions/diagnostic criteria for preeclampsia are generally similar worldwide except the International Society for the Study of Hypertension in Pregnancy definition also includes signs of uteroplacental dysfunction (eg, fetal growth restriction, abnormal angiogenic markers, abnormal umbilical artery Doppler, abruption, fetal demise)."},"gt0003":{"id":"gt0003","text":"*(en) Quantitative urinary protein"},"gt0005":{"id":"gt0005","text":"*(en) Preeclampsia"},"gt0007":{"id":"gt0007","text":"*(en) Observations"},"gt0009":{"id":"gt0009","text":"*(en) Urine Creatinine"},"gt0017":{"id":"gt0017","text":"*(en) Systolic"},"gt0018":{"id":"gt0018","text":"*(en) Diastolic"},"gt0019":{"id":"gt0019","text":"*(en) 1 Proteinuria","description":"*(en) Proteinuria ≥0.3 g in a 24-hour urine specimen or protein/creatinine ratio ≥0.3 (30 mg/mmol) in a random urine specimen or dipstick ≥2+ if a quantitative measurement is unavailable"},"gt0020":{"id":"gt0020","text":"*(en) 2 Platelet","description":"*(en) Platelet count <100,000/microL"},"gt0021":{"id":"gt0021","text":"*(en) 3 creatinine","description":"*(en) Serum creatinine >1.1 mg/dL (97.2 micromol/L) or doubling of the creatinine concentration in the absence of other kidney disease"},"gt0022":{"id":"gt0022","text":"*(en) 4 transaminases","description":"*(en) Liver transaminases at least twice the upper limit of the normal concentrations for the local laboratory"},"gt0023":{"id":"gt0023","text":"*(en) 5 Pulmonary edema","description":"*(en) Pulmonary edema present"},"gt0024":{"id":"gt0024","text":"*(en) 6 headache","description":"*(en) New-onset and persistent headache not accounted for by alternative diagnoses and not responding to usual doses of analgesics (Response to analgesia does not exclude the possibility of preeclampsia)."},"gt0025":{"id":"gt0025","text":"*(en) 7 Visual symptoms","description":"*(en) Visual symptoms (eg, blurred vision, flashing lights or sparks, scotomata)"},"gt0027":{"id":"gt0027","text":"*(en) Pulmonary edema"},"gt0029":{"id":"gt0029","text":"*(en) Liver transaminases at least twice the upper limit"},"gt0031":{"id":"gt0031","text":"*(en) Headache"},"gt0032":{"id":"gt0032","text":"*(en) Visual symptoms (eg, blurred vision, flashing lights or sparks, scotomata)"},"gt0033":{"id":"gt0033","text":"*(en) Proteinuria ≥0.3 g in a 24-hour urine"},"gt0034":{"id":"gt0034","text":"*(en) Dipstick ≥2+"},"gt0035":{"id":"gt0035","text":"*(en) Platelet count <100,000/microL"},"gt0036":{"id":"gt0036","text":"*(en) Serum creatinine >1.1 mg/dL (97.2 micromol/L)"},"gt0037":{"id":"gt0037","text":"*(en) Doubling of the creatinine concentration (no kidney disease)"},"gt0038":{"id":"gt0038","text":"*(en) 8 blood pressure","description":"*(en) If systolic blood pressure is ≥160 mmHg and/or diastolic blood pressure is ≥110 mmHg, confirmation within minutes is sufficient."}}}},"term_bindings":{}}}